05:32 PM EDT, 05/06/2024 (MT Newswires) -- Michael Landsittel, CFO, on May 02, 2024, sold 10,000 shares in Blueprint Medicines ( BPMC ) for $1,050,000. Following the Form 4 filing with the SEC, Landsittel has control over a total of 47,286 shares of the company, with 47,286 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924012359/xslF345X03/form4-05062024_090549.xml

Price: 105.04, Change: -1.21, Percent Change: -1.14